Connect your AI

Solventum SOLV Short-term debt and current portion of long-term debt

Short-term debt and current portion of long-term debt at other companies

Becton, Dickinson and CompanyBDX

$2.57B+60.4%

3MMMM

$1.65B+41.1%

UnitedHealth GroupUNH

$6.48B-35.1%

StrykerSYK

$499M-79.2%

Boston ScientificBSX

$41M-94.7%

Medline, Inc. MDLN

——

Other financials

Income statement

Revenue$2.0B-3.0%

Gross profit$1.1B-1.5%

Operating income$81.0M-46.7%

Net income$13.0M-90.5%

EPS (diluted)$0.07-91.0%

Balance sheet

Cash & equivalents$561.0M+5.1%

Total debt$5.8B-26.8%

Total equity$5.0B+52.3%

Total assets$14.1B-3.0%

Cash flow

Operating cash flow-$189.0M-752%

CapEx$84.0M-22.9%

Free cash flow-$273.0M-241%

Valuation

Market cap$13.06B-13.9%

Enterprise value$18.29B-19.4%

P/E9.1×-30.9×

P/S1.6×-0.2×

Profitability

Gross margin53.7%-0.9pp

Operating margin25.5%+15.8pp

Net margin17.3%+12.8pp

FCF margin4.6%-13.9pp

Returns & leverage

Return on equity34.8%+24.1pp

Debt / equity1.2×-1.3×

Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:DebtCurrent.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's short-term debt and current portion of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Solventum's short-term debt and current portion of long-term debt?: Solventum (SOLV) reported short-term debt and current portion of long-term debt of $505M in Q1 2026.
How has Solventum's short-term debt and current portion of long-term debt changed year-over-year?: Solventum's short-term debt and current portion of long-term debt increased by 405.0% year-over-year, from $100M to $505M.